Chemical inhibitors of TMCC3 can exert their inhibitory effects through various mechanisms, primarily by interfering with signaling pathways and cellular processes that TMCC3 is known to be involved in. Alsterpaullone, by acting as a cyclin-dependent kinase inhibitor, can disrupt cell cycle progression, leading to the inhibition of TMCC3's role in cell cycle-related events. Similarly, SB-216763 targets glycogen synthase kinase 3 (GSK-3), a key player in the Wnt signaling pathway, and its inhibition could reduce the participation of TMCC3 in transport processes that are dependent on Wnt signaling and β-catenin stability. The MEK inhibitor PD-98059 can suppress the ERK/MAPK pathway, potentially limiting TMCC3's involvement in signaling cascades that regulate vesicular transport and membrane trafficking. Another kinase inhibitor, Y-27632, targets Rho-associated protein kinase (ROCK), and its inhibition can lead to reduced cytoskeletal rearrangements, affecting TMCC3's role in vesicular trafficking and cellular migration.
In addition to these, LY294002 and Wortmannin, both inhibitors of phosphoinositide 3-kinases (PI3K), can hinder the PI3K/Akt pathway, which is crucial for a variety of cellular processes including vesicle formation and trafficking where TMCC3 may be implicated. The JNK inhibitor SP600125 can inhibit TMCC3 by blocking signaling pathways that are activated during cellular stress responses. U0126, which inhibits MEK1/2, and BIX 02189, which inhibits MEK5, both lead to the downregulation of the MAPK signaling pathway, potentially impacting TMCC3's role in vesicle sorting and transport, as well as in cellular differentiation. Gö 6983 acts on protein kinase C (PKC), and by inhibiting this kinase, it could affect TMCC3's function in mediating vesicle-mediated transport and cellular communication. PP2, an Src family kinase inhibitor, can disrupt signaling that influences cellular adhesion and migration, processes in which TMCC3 may play a part. Lastly, Dorsomorphin, by inhibiting BMP signaling and AMPK, can impede TMCC3's function in developmental processes and cellular differentiation pathways. Each chemical, by targeting specific pathways and kinases, can contribute to the functional inhibition of TMCC3, thereby impeding its role in the complex network of cellular signaling and transport.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is a cyclin-dependent kinase inhibitor that can inhibit TMCC3 by blocking cell cycle progression, thereby preventing the protein from performing its role in cell cycle-related events. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
SB-216763 inhibits glycogen synthase kinase 3 (GSK-3), which is involved in Wnt signaling. Inhibition of GSK-3 stabilizes β-catenin, hence potentially reducing the availability of β-catenin for TMCC3-dependent transport processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD-98059 is a MEK inhibitor which can result in the inhibition of the ERK/MAPK pathway, potentially reducing TMCC3 involvement in signaling cascades that rely on this pathway for vesicular transport and membrane trafficking. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor, and by inhibiting ROCK, it can reduce cytoskeletal rearrangements where TMCC3 is involved in vesicular trafficking and cellular migration processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which can impede the PI3K/Akt pathway, possibly inhibiting TMCC3's role in cellular processes that are dependent on this signaling for vesicle formation and trafficking. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that may prevent the function of TMCC3 by inhibiting JNK-mediated signaling pathways, which are implicated in cellular stress responses where TMCC3 might play a role. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2 leading to the suppression of the ERK/MAPK pathway, potentially inhibiting the function of TMCC3 in pathways that depend on MAPK signaling for vesicle sorting and transport. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a protein kinase C inhibitor that can inhibit TMCC3 by blocking PKC-mediated signaling pathways, which may be necessary for TMCC3's role in vesicle-mediated transport and cellular communication. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor which can inhibit TMCC3 by impeding PI3K/Akt pathway signaling, potentially affecting TMCC3-dependent processes like vesicle formation and trafficking. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor which can inhibit TMCC3 by preventing Src family kinase signaling, potentially impacting TMCC3's role in cellular adhesion and migration. | ||||||